Siemens Healthineers (ETR:SHL) Given a €56.00 Price Target by UBS Group Analysts

Siemens Healthineers (ETR:SHLGet Rating) has been given a €56.00 ($56.00) price target by research analysts at UBS Group in a research note issued on Wednesday, Borsen Zeitung reports. UBS Group’s target price would suggest a potential upside of 8.32% from the stock’s previous close.

A number of other analysts have also weighed in on SHL. JPMorgan Chase & Co. set a €63.10 ($63.10) target price on Siemens Healthineers in a research note on Wednesday. Jefferies Financial Group set a €53.00 ($53.00) target price on Siemens Healthineers in a research note on Wednesday. Deutsche Bank Aktiengesellschaft set a €64.00 ($64.00) price objective on Siemens Healthineers in a research report on Wednesday, August 3rd. Barclays set a €62.00 ($62.00) price objective on Siemens Healthineers in a research report on Wednesday. Finally, Berenberg Bank set a €54.00 ($54.00) price objective on Siemens Healthineers in a research report on Tuesday.

Siemens Healthineers Stock Performance

Shares of ETR:SHL opened at €51.70 ($51.70) on Wednesday. Siemens Healthineers has a twelve month low of €40.32 ($40.32) and a twelve month high of €67.66 ($67.66). The firm has a market cap of $58.04 billion and a PE ratio of 29.42. The company has a debt-to-equity ratio of 85.17, a quick ratio of 0.59 and a current ratio of 1.01. The business has a fifty day moving average of €45.70 and a 200-day moving average of €48.92.

Siemens Healthineers Company Profile

(Get Rating)

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. The company operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems.

Further Reading

Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.